ADAG (Adagene Inc. American Depositary Shares) Stock Analysis - AI Report

Adagene Inc. American Depositary Shares (ADAG) is a publicly traded Healthcare sector company. As of May 21, 2026, ADAG trades at $3.45 with a market cap of $223.99M and a P/E ratio of 0.00. ADAG moved -1.91% today. Year to date, ADAG is +93.82%; over the trailing twelve months it is +121.15%. Its 52-week range spans $1.30 to $4.75. Analyst consensus is strong buy with an average price target of $8.33. Rallies surfaces ADAG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on ADAG?

Rallies AI research for ADAG combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

ADAG Key Metrics

Key financial metrics for ADAG
MetricValue
Price$3.45
Market Cap$223.99M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$4.75
52-Week Low$1.30
Volume0
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest ADAG News

ADAG Analyst Consensus

3 analysts cover ADAG: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.33.

Common questions about ADAG

What is the AI research view on ADAG?
Rallies AI research for ADAG combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for ADAG?
Rallies AI research for ADAG combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is ADAG research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ADAG. It does not provide personalized investment advice.
ADAG

ADAG